Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates

Clinical trial NCT02564718 · COMPLETED

Trial details

NCT number: NCT02564718
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Thromboembolism

Start date: 2015-11-19
Primary completion: 2017-12-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.